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Autocrine Actions of Matrix Metalloproteinase
(MMP)-2 Counter the Effects of MMP-9 to Promote
Survival and Prevent Terminal Differentiation of
Cultured Human Keratinocytes
Meilang Xue1 and Christopher J. Jackson1
Cultured human keratinocytes produce matrix metalloproteinase (MMP)-2 and MMP-9. In this study, using small
interfering RNA (siRNA) for MMP-2 or MMP-9, we investigated the functions of these two gelatinases in the
regulation of survival by measuring growth, differentiation, apoptosis, and migration of cultured keratinocytes.
MMP-2 siRNA treatment significantly decreased keratinocyte growth and migration, and stimulated apoptosis
fourfold. In addition, MMP-2 siRNA caused a 70% reduction in keratin-14 (K14) and a fourfold increase in K10. In
contrast, MMP-9 siRNA treatment exerted opposite effects on cell growth, apoptosis, and K10 expression. MMP-2
appears to act through the ERK MAP kinase and caspase-3 signaling pathways as evidenced by the 53%
reduction in the level of phosphorylated ERK1/2 and threefold increase in phosphorylated p38 and stronger
staining for active caspase-3 in response to MMP-2 siRNA. Dual fluorescent staining revealed that almost all
cultured cells stained positive for MMP-2, with only a few scattered cells being positive for MMP-9. There were
considerably more BrdU-positive cells following MMP-9 siRNA treatment, indicating that MMP-9 inhibited
proliferation. In conclusion, MMP-2 stimulates keratinocyte survival whereas MMP-9 promotes terminal
differentiation.
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INTRODUCTION
Matrix metalloproteinases (MMPs) are a family of structurally
related zinc- and calcium-dependent endopeptides capable
of degrading extracellular components (Sternlicht and Werb,
2001). A number of studies have demonstrated that MMPs are
important mediators in both physiological and pathological
conditions. Of considerable importance are the gelatinase
subfamily of MMPs, consisting of MMP-2 (gelatinase-A) and
MMP-9 (gelatinase-B), as they not only degrade both native
and denatured collagens, elastin, aggrecan, and fibronectin,
but also cleave growth factors, cytokines/chemokines, by
proteolysis (Gearing et al., 1994; Schonbeck et al., 1998;
Bergers et al., 2000; McQuibban et al., 2000, 2001, 2002),
and are directly involved in regulation of cell migration,
proliferation, inflammation, and death.
Although MMP-2 and MMP-9 share many similarities in
structure and substrates, they differ fundamentally in terms of
regulation and activation (Visse and Nagase, 2003). In
general, MMP-2 is produced constitutively by a wide range
of cell types, including fibroblasts, endothelial cells, kerati-
nocytes, and macrophages. Most proinflammatory stimuli fail
to increase MMP-2 transcription. In contrast, constitutive
expression of MMP-9 is restricted to leukocytes, with most
other cell types expressing MMP-9 in response to inflamma-
tory stimulation.
Like many other MMPs, MMP-9 can be activated by
several proteases, including plasmin and MMP-3. The
activation of MMP-2 is more complex, involving MT1-
MMP, tissue inhibitor of MMP-2, and pro-MMP-2. Some
other selective activators of MMP-2, including the natural
anti-coagulant, activated protein C (APC), have been
described (Nguyen et al., 2000). In knockout mice, loss
of MMP-2 disrupts skeletal and craniofacial development,
and results in decreased bone mineralization, joint erosion,
and defects in osteoblast and osteoclast growth (Mosig et al.,
2007). These mice also develop exacerbated antibody-
induced arthritis (Itoh et al., 2002). Targeted deletion of
MMP-9 attenuates myocardial contractile dysfunction in
heart failure (Moshal et al., 2007), reduces severity of
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antibody-induced arthritis (Itoh et al., 2002), shows neuro-
protective effects in the development of hypoxic–ischemic
injury in the immature brain (Svedin et al., 2007), and plays a
protective role in the host defense against Escherichia coli-
induced peritonitis (Renckens et al., 2006). In all these cases,
no compensation by MMP-2 in MMP-9-deficient mice or
MMP-9 in MMP-2-deficient mice is detectable, suggesting
that MMP-2 and MMP-9 act independently in vivo.
The epidermis is the outermost skin layer and provides the
first line of defense against the external environment.
Keratinocytes, the predominant cell type in human skin,
exist at various stages of differentiation corresponding to
different epidermal layers (Bikle et al., 2001; Dransfield et al.,
2001). Dividing cells in the basal layer progressively
differentiate and withdraw from the cell cycle as they move
toward the skin surface. Keratinocytes play a fundamental
role in skin metabolism and in wound closure, by proliferat-
ing and migrating to compensate for superficial cell loss or to
cover the exposed connective tissue, and by producing
various mediators, including cytokines/chemokines and
MMPs (Pivarcsi et al., 2004). In vivo, MMP-2 is constitutively
expressed in normal skin and in the epidermis (Oikarinen
et al., 1993), while expression of MMP-9 is almost always
associated with inflammatory conditions such as psoriasis
and chronic wounds (Cordiali-Fei et al., 2006; Rayment et al.,
2008). In culture, human keratinocytes produce both MMP-2
and MMP-9. In this study, we examined the functional role of
keratinocyte-derived MMPs in the cell survival and differ-
entiation by using small interfering (si)RNAs.
RESULTS
MMP-2 and MMP-9 differentially regulate keratinocyte growth,
migration and apoptosis
To explore the functional role of MMP-2 and MMP-9 on
keratinocyte survival, cells treated with the respective siRNAs
were assayed for cell growth, apoptosis, and differentiation.
The efficacy of specific siRNA was first examined by reverse
transcription real time PCR. Treatment of keratinocytes with
siRNA for MMP-2 or MMP-9 inhibited the respective gene
expression by more than 90%, 48 hours after transfection
(Figure 1a and c). Accordingly, there were reductions in
MMP-2 and MMP-9 protein detected in culture supernatant at
72 hours by zymography (Figure 1b and d). There was no
compensatory increase in MMP-2 expression upon addition
of MMP-9 siRNA or vice versa (Figure 1b and d), nor was
there any increase in activity upon addition of the two siRNAs
together (Figure 1a and c). Combining both siRNAs showed
similar efficacy in suppression of individual gene expression
(Figure 1a and c).
Following siRNA treatment, cell number and viability
were measured at 24, 48, and 72 hours by trypan blue
exclusion test and the colorimetric 3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay. Inhibi-
tion of MMP-2 by its specific siRNA decreased cell growth by
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Figure 1. Differential effect of MMP-2 and MMP-9 on keratinocyte viability. (a, c) Efficacy of MMP-2 and MMP-9 siRNAs at blocking their respective mRNA
expression by keratinocytes in separate or combined conditions at 48 hours, detected by reverse transcription real time PCR. Data are expressed as percentage of
scrambled siRNA control (mean±SEM, n¼ 3). (b, d) MMP-2 and MMP-9 protein expression in culture medium after cells were transfected with siRNA for
72 hours, detected by zymography. (e) Viability of keratinocytes in response to MMP-2 and MMP-9 siRNA (10 nM), and recombinant (r) MMP-2 and MMP-9
(0.1 and 10 ngml1), treatment after 72 hours as detected by MTT assay. Cell viability is expressed as a percentage of scrambled siRNA control (mean±SD).
* indicates comparison with scrambled siRNA control and þ indicates in comparison with relevant MMP siRNA treatment conditions; * and þ , Po0.05.
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approximately 10% at 24 hours, 20% at 48 hours, and 25% at
72 hours (Figure 1e), whereas MMP-9 siRNA increased
growth by approximately 8% at 24 hours, 10% at 48 hours,
and 12.5% at 72 hours (Figure 1e). When cells were
transfected with both siRNAs simultaneously, cell growth
was inhibited by B10% at 72 hours (Figure 1e), which
indicates that the opposing effects of these siRNAs on cell
proliferation are additive. To confirm these data, transfected
cells were treated with recombinant (r) forms of each
gelatinase. rMMP-2 significantly rescued cell growth inhibi-
tion induced by MMP-2 siRNA; similarly, rMMP-9 reversed
the stimulatory effect of MMP-9 siRNA (Figure 1e). Interest-
ingly, rMMP-2 and rMMP-9 were unable to completely
reverse the effect of their specific siRNAs when used at even
higher concentrations (20, 50 ngml1, data not shown),
suggesting that there are functional differences between
exogenous and endogenous gelatinases in keratinocytes.
Cell migration was measured at 48 hours after siRNA
transfection. Inhibition of MMP-2 by its siRNA suppressed
cell migration by more than 30% (Figure 2). Similarly, MMP-9
siRNA treatment decreased cell migration by B20%
(Figure 2). Combination treatment with siRNAs for MMP-2
and MMP-9 resulted in a similar decrease in migration as that
with each siRNA alone (Figure 2), suggesting that both
gelatinases contributed to cell migration.
Apoptosis was assessed 48 hours after cells were trans-
fected with MMP-2 or MMP-9 siRNA, using a modified
ethidium bromide and acridine orange staining assay, which
detects apoptotic cells containing condensed or fragmented
chromatin. Cells treated with MMP-2 siRNA had a more than
fourfold higher rate of apoptosis compared with cells treated
with scrambled (control) siRNA (Figure 3a and b). In contrast,
suppression of MMP-9 by siRNA did not affect apoptosis
significantly (Figure 3a and b). Cells treated simultaneously
with siRNAs for both gelatinases were significantly less
apoptotic compared with those treated with MMP-2 siRNA
alone. To further confirm these data, BrdU was incorporated
into cells. There were considerably fewer cells treated with
either MMP-2 siRNA or MMP-2 siRNA plus MMP-9 siRNA
that were BrdU-positive, when compared with either MMP-9
siRNA or control siRNA-treated cells (Figure 4c). Further-
more, MMP-2 siRNA-treated cells displayed stronger staining
for activated caspse-3 (Figure 3c).
Overall, the above experiments clearly show that endo-
genous MMP-2 promotes keratinocyte survival in an auto-
crine manner, whereas MMP-9 has opposing effects.
Disparate effects of MMP-2 and MMP-9 on keratinocyte
differential markers, keratin-10 (K10) and K14
K14 is expressed by basal keratinocytes and gradually
replaced by K1 and K10 in the suprabasal layers during
terminal differentiation (Bowden et al., 1987). In response to
MMP-2 siRNA treatment for 72 hours, K14 expression was
decreased by more than 70% and K10 expression increased
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Figure 2. MMP-2 and MMP-9 siRNA both inhibit keratinocyte migration. (a) Cell monolayers were pretreated with mitomycin C and then scratched
with a 1,000-ml blue plastic pipette tip. The defined area of the wound was photographed by phase-contrast microscopy at time 0 (0 hour). To standardize
the position of the wound for photography, small indents were made in the plastic wells (marked as block arrows). Cell migration was determined after
24 hours by counting the cells that had moved out of the initial area, and (b) the percentage of cell migration calculated as follows: (number of migrated
siRNA-treated cells/number of migrated scrambled siRNA-treated cells) 100. Data are expressed as the number of migrated cells as a percentage of
control (mean±SEM, n¼3 experiments). Images represent one of three independent experiments; *Po0.05. Bar¼ 100mm.
2678 Journal of Investigative Dermatology (2008), Volume 128
M Xue and CJ Jackson
Autocrine MMP-2 Promotes Keratinocyte Survival
more than fourfold (Figure 4a and c). In contrast, MMP-9
siRNA treatment had no significant effect on the expression of
K14, but decreased the expression of K10 after transfection
for 72 hours (Figure 4a and c). The combination of MMP-2
siRNA plus MMP-9 siRNAs enhanced K10 expression four-
fold, but had no effect on the expression of K14 (Figure 4a
and c). The addition of rMMP-2 or rMMP-9 for 24 hours did
not affect K10’s expression; however, rMMP-2 significantly
increased K14 expression 1.5-fold (Figure 4b and d). These
results indicate that endogenous MMP-2 induces K14
expression and prevents expression of terminal differentiation
marker K10 in an autocrine manner.
Immunofluorescent staining of unstimulated cells revealed
that MMP-2 was associated with almost all cells (Figure 5a),
whereas only a small proportion (o5%) of cells were positive
for MMP-9 (Figure 5a). These cells were confirmed to be
keratinocytes by their positive staining for K10 and K14,
which ruled out the possibility of contamination by other
cells. Cultured keratinocytes strongly expressed K14 (Figure
5a), the marker for basal keratinocytes, whereas K10, a
terminal differential marker of keratinocytes, was present
only on a few scattered cells (Figure 5a). Dual fluorescent
staining confirmed that MMP-2 was associated with K14-
positive cells, whereas MMP-9 was associated with K10-
positive cells (Figure 5a). These results are consistent with
gelatinase expression on neonatal foreskin sections, which
showed that MMP-2 is strongly expressed by the basal and
suparabasal layers of epidermis, whereas MMP-9 displayed
very weak staining throughout the epidermis (Figure 5b).
Differential effect of MMP-2 and MMP-9 on activation
of MAP kinase and EGFR
Cell proliferation and apoptosis are partly controlled through
activation of mitogen-activated protein (MAP) kinases, extra-
cellular signal-regulated kinase-1/2 (ERK1/2), and p38. We
examined the effect of MMP-2 and MMP-9 siRNA on the
activity of MAP kinase. Treatment of cells with MMP-2 siRNA
for 72 hours caused more than 50% inhibition of ERK2
phosphorylation, whereas elevating the expression of the
phosphorylated form of p38 by B4-fold. In response to
MMP-9 siRNA, there were no significant changes in the phosphor-
ylation of ERK2 or p38. However, treatment with both
MMP-2 andMMP-9 siRNAs enhanced the level of phosphorylated
p38 by approximately fourfold, but had no significant effect
on the phosphorylation of ERK2 (Figure 6a and c). Further
experiments were performed by treating cells with recombi-
nant gelatinases for 24 hours. rMMP-2 (20 ngml1) signifi-
cantly increased phosphorylation of ERK2, whereas rMMP-9
had little effect on the activity of MAP kinases (Figure 6b and
d). Overall, these results indicate that MMP-2 increases the
activation of ERK-2, but prevents activation of p38 in
keratinocytes. Interestingly, the expression of the phosphory-
lated form of epidermal growth factor receptor (EGFR), a
receptor playing a central role in numerous aspects of
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Figure 3. Endogenous MMP-2 prevents keratinocyte apoptosis. Keratinocytes were treated with 10 nM control siRNA, 10 nM MMP-2 siRNA, 10 nM MMP-9
siRNA, or both (mixture siRNA) and seeded into a 96-well plate. (a) After a 48-hour incubation period, apoptotic cells were detected by ethidium bromide and
acridine orange staining. Arrows indicate examples of apoptotic cells. Bar¼ 20mm. (b) Quantification of apoptotic cells by counting them by high-power
microscopy ( 20). Data are expressed as the percentage of average apoptotic cells from 15 fields following control siRNA treatment (mean±SEM, n¼ 3
experiments). *Po0.05, **Po0.01 compared with control siRNA treatment. (c) BrdU and active caspase-3 staining in keratinocytes, in the presence or absence
of the nuclear stain, 4’,6-diamidino-2-phenylindole (DAPI). Arrows indicate examples of cells positive for both DAPI and BrdU or active caspase-3. Bar¼ 20 mm.
Images represent result of one of three independent experiments.
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keratinocyte biology, including proliferation, was markedly
increased following MMP-9 siRNA treatment, but was not
affected by MMP-2 siRNA (Figure 6a and c).
DISCUSSION
This study reveals a differential function for gelatinases, as
autocrine regulators of keratinocyte proliferation, apoptosis,
and differentiation. Endogenous MMP-2 promotes survival
and inhibits differentiation, whereas MMP-9 promotes
terminal differentiation (summarized in Figure 7). To our
knowledge this is previously unreported. Furthermore, the
protective autocrine actions of MMP-2 on cell survival
counter the inhibitory effects of MMP-9 and prevent terminal
differentiation of human keratinocyte in culture.
The autocrine requirement of MMP-2 for cell proliferation
has been described in human airway smooth-muscle cells
(Johnson and Knox, 1999), human SaOS2, and murine
MC3T3 osteoblast cell lines (Mosig et al., 2007). Here we
provide the first evidence showing that MMP-2 is required
for human keratinocyte proliferation and that MMP-2 and
MMP-9 have disparate autocrine effects on keratinocyte
growth. Inhibition of MMP-2 by its siRNA suppressed cell
growth and addition of MMP-2 reversed this effect, whereas
MMP-9 siRNA significantly stimulated cell growth. APC,
recently shown to increase keratinocyte growth and viability
(Xue et al., 2007), stimulated MMP-2 production (Xue et al.,
2004; Jackson et al., 2005). The inhibitory effect of MMP-2
siRNA on keratinocyte growth appears to occur through
induction of cell differentiation, as discussed below, and cell
apoptosis. A more than fourfold higher number of apoptotic
cells and stronger staining for active caspase-3 were found in
MMP-2 siRNA-treated cells. Overall, these data show that
MMP-2 stimulates, while MMP-9 inhibits, keratinocyte survival.
Normally, in the epidermis K5, K14, and K15 are
expressed in basal proliferating keratinocytes. When kerati-
nocytes begin to stratify and differentiate, they acquire the
differentiation-specific keratins K1 and K10 (Bowden et al.,
1987). Ectopic expression of K10 in the basal epidermis of
transgenic mice leads to strong decrease in proliferation and
reduced tumorigenesis (Hudson and McCawley, 1998;
Santos et al., 2002; Reichelt et al., 2004). During skin tumor
progression, K1/K10 expression is lost, suggesting a possible
suppressor role for these keratins in cell growth (Santos et al.,
2002). Results from cell transfection experiments indicate a
direct role for K10 in inhibition of cell-cycle entry by
sequestration of Akt kinase (Santos et al., 2002). When
cultured in low-calcium medium, normal keratinocytes
express K14 but not K1 or K10; however, high (2mM)
concentration of Ca2þ induces expression of K1 and K10,
and differentiation (Pillai et al., 1990). In this study,
immuofluorescent staining showed that normal cultured
keratinocytes displayed strong staining for K14 and minimal
immune activity for K10. When cells were transfected with
MMP-2 siRNA, they expressed significantly less K14 and
more K10, indicative of a more differentiated phenotype.
The addition of rMMP-2 to these cells regenerated K14
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Figure 4. Differential effect of MMP-2 and MMP-9 on the expression of K14 and K10. Keratinocytes were treated with MMP-2 and/or MMP-9 siRNA for
72 hours and/or recombinant rMMP-2 or MMP-9 for 24 hours. The protein levels of K14 and K10 were detected by western blotting in whole cell lysates from
(a) cells transfected with MMP-2 and/or MMP-9 siRNA and (b) cells treated with rMMP-2 or MMP-9 (20 ngml1). (c, d) Western blotting results were analyzed
by image analysis software. Data are expressed as a percentage of control protein expression (mean±SEM, n¼ 3 experiments). *Po0.05, **Po0.01. Images of
gels represent result of one of three independent experiments.
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expression. The increase in K10 expression by MMP-2 siRNA
provides direct evidence that MMP-2 prevents terminal
differentiation. Our results are consistent with those of
previous studies showing that MMP-2 is decreased in late-
passage differentiated keratinocytes (Kobayashi et al., 1998),
and the terminal differentiation marker, involucrin, is
colocalized with MMP-9 in the keratinocytes treated with
high concentrations of Ca2þ (Kobayashi et al., 2001).
There was no significant change in MAP kinase activity in
cells transfected with MMP-9 siRNA. However, activation of
EGFR was remarkably increased in MMP-9 siRNA-treated
cells. EGFR, a member of the ErbB family of receptor tyrosine
kinases, plays an important role in regulating the develop-
ment of the epidermis and its appendages (Jost et al., 2001).
In normal epidermis, EGFR is essential for numerous aspects
of keratinocyte biology, including viability, growth, regula-
tion of cell migration, and suppression of terminal differ-
entiation (Hudson and McCawley, 1998). Functional
activation of EGFR results from increased phosphorylation
of specific tyrosine residues in its C-terminal cytoplasmic
domain. EGFR’s activation in the presence of MMP-9 siRNA
suggests that MMP-9 is a natural negative regulator of EGFR.
This may explain the inhibitory effect of MMP-9 on the
growth of keratinocyte, although the exact mechanism
underlying MMP-9’s inhibition of EGFR phosphorylation
remains unclear.
The MAP kinase pathway is a prerequisite for growth factor-
stimulated mitogenesis and differentiation in many cell types
(Roux and Blenis, 2004). Three of the major downstream MAPK
cascades are mitogen-activated ERK1/2 and stress/cytokine
activated p38 and c-Jun N-terminal kinases. We have previously
demonstrated in human keratinocytes that ERK1/2 is the major
MAP kinase associated with APC’s enhancement of cell growth/
viability, whereas p38 exhibits opposing effects to ERK2 (Xue
et al., 2007). In this study, inhibition of MMP-2 suppressed
activation of ERK2 while markedly activated p38. These results
are in keeping with results of previous studies, which show that
p38 MAP kinase functions to promote differentiation and
apoptosis, while signaling through ERK promotes keratinocyte
proliferation and survival (Eckert et al., 2002). Further studies
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K14 Merged
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K10 Merged
Figure 5. Localization of MMP-9 and MMP-2 in keratinocytes and foreskin tissue. (a) Colocalization of MMP-2 with K14, and MMP-9 with K10. Images
on the right are a merged form of the images on the left. Yellow indicates colocalization. Bar¼20 mm. White arrows indicate positively stained cells.
(b) MMP-2 and MMP-9 immunostaining in neonatal foreskin tissue sections. Control IgG did not stain positively (data not shown). Bar¼10 mm. Images
represent result of one of three independent experiments.
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are required to elucidate the mechanism of MMP-2’s action
upstream of MAP kinase intracellular signaling.
In contrast to their opposing effects on growth, both
MMP-2 and MMP-9 are required for keratinocyte migration.
In general, within 24 hours of wounding, keratinocytes from
the wound margins begin to migrate into the wound bed,
where they re-epithelialize the exposed tissue. MMPs from
keratinocytes contribute to cutaneous wound repair not
only by degrading ECM, but also by regulating cell migration
(Madlener, 1998; Xue et al., 2006). The important role
of MMPs in epithelialization has been demonstrated in
experimental wound models (Agren, 1999; Lund et al.,
1999). MMP-2 is localized immunohistochemically to
fibroblasts and endothelial cells in the dermo-epidermal
junction and is constitutively expressed in normal skin and
epidermis (Oikarinen et al., 1993). Ashcroft et al. (1997)
immunodetected MMP-2 in cryosections of migrating epithe-
lium in small full-thickness skin wounds in humans. The
exact role of MMP-9 during wound healing is less clear.
Agren et al. (2001) found that whereas MMP-2 is required for
keratinocyte migration, MMP-9 is not necessary. It is possible
that MMP-9 cleaves collagens type IV and type V in the
basement membrane during the early stages of the migration
process to detach keratinocytes from their matrix (Salo et al.,
1994). However, Mohan et al. (2002) used MMP-9-deficient
mice to show that MMP-9, in contrast to other MMPs
expressed at the front of the advancing epithelial sheet in
wounds of cornea, skin, or trachea, inhibits the rate of wound
closure. Interestingly, they found this reduction in healing to
be due to control of epithelial replication, which is strongly
supported by our current findings.
This study has revealed differential effects of the two
members of the gelatinase family on skin keratinocytes
(outlined in Figure 7). We show that MMP-2 acts in
an autocrine manner to promote survival and dampen
differentiation, whereas MMP-9 causes terminal differen-
tiation. These findings suggest that selective elevation
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Figure 6. Differential effect of MMP-2 and MMP-9 on the activation of p38, ERK2, and EGFR. Keratinocytes were treated with MMP-2 or MMP-9 siRNA
for 72 hours and/or recombinant rMMP-2 or MMP-9 for 24 hours. The phosphorylated forms of p38, ERK2, or EGFR were detected by western blotting
in whole-cell lysates for (a) cells transfected with MMP-2 and/or MMP-9 siRNA, and (c) cells treated with rMMP-2 or MMP-9 (20 ngml1). (b, d) Western
blotting results were analyzed by image analysis software. Data are expressed as a percentage of control protein expression (mean±SEM, n¼ 3 experiments).
P, phosphorylated. *Po 0.05, **Po0.01. Images represent result of one of three independent experiments.
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Figure 7. Autocrine actions of MMP-2 and MMP-9 from human skin
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of MMP-2 and inhibition of MMP-9 activity in skin may
benefit wound healing and inflammatory skin diseases, such
as psoriasis.
MATERIALS AND METHODS
Keratinocyte culture and treatment
Normal keratinocytes were isolated from neonatal foreskins as
described previously (Xue et al., 2004). The medical ethical
committee of Northern Sydney & Central Coast Health Human
Research approved all described studies. The study was conducted
according to Declaration of Helsinki Principles and all participants
gave written informed consent. Cells were cultured in keratinocyte-
serum free medium (Gibco, Invitrogen Corp., Lakewood, NJ) to 70%
confluence. Cells were trypsinized and seeded into 24-well culture
plates at a density of 1 105 cells per well and incubated for
12 hours to allow cell adhesion.
siRNA preparation and nucleofection
siRNA duplex oligonucleotides were purchased from Proligo (Sigma-
Proligo, St Louis, MO). The siRNAs used in this study for MMP-2 and
MMP-9 have been previously described and validated (Auge et al.,
2004; Meyer et al., 2005). Scrambled forms of siRNAs were used as a
negative control. The amount of keratinocytes was adjusted to
1.5 105 cellsml1 in growth medium and subjected to nucleofec-
tion using the siPORT NeoFX solution according to the manufac-
turer’s instructions (Amaxa Biosystems, Cologne, Germany). Cells
were transfected and allowed to attach overnight. The transfected
cells were then trypsinized and seeded into either 24-well plates
(1 105 cells per well), eight-well permanox slides (Nalge Nunc
International Corp., Rochester, NY) or 96-well plates (2 103 cells
per well) and incubated for further 24, 48, or 72 hours.
RNA extraction and reverse transcription–real-time PCR
Total RNA was extracted from keratinocytes using Tri Reagent
(Sigma) according to the manufacturer’s instructions. Single-stranded
cDNA was synthesized from total RNA using AMV reverse
transcriptase and oligo-(dT)15 as a primer (Promega Corp., Madison,
WI). The levels of mRNA were semi-quantified by real time PCR with
a Rotor-gene 3000A (Corbett Research, Sydney, Australia) by
normalizing to the expression of the housekeeping gene RPL13A.
Primers used were as follows: MMP-2 (NM-004530): sense
50CGCTCAGATCCGTGGTGAG, antisense 50TGTCACGTGGCGTC
ACAGT; MMP-9 (NM-004994): sense 50CTGGGCAGATTCCAAA
CCT, antisense 50CGGCAAGTCTTCCGAGTAGT; and RPL13A
(NM-012423): sense 50AAGCCTACAAGAAAGTTTGCCTATC, anti-
sense 50TGTTTCCGTAGCCTCATGAGC.
MTT assay
MTT assay was performed to quantitate the effect of different test
agents on cell growth and viability. Briefly, 2 103 cells were
seeded into a 96-well microplate to a final volume of 200 ml well1
and were treated with different test agents. Three hours prior to
completion of treatment, 5ml of 5mgml1 MTT (Sigma) was added
to cells. After a further 3-hour incubation period, the MTT solution
was removed and replaced by 100ml DMSO. The optical density of
each well was determined at a wavelength of 570 nm, with a
reference wavelength of 630 nm. Results were expressed as
percentages of controls.
In vitro migration assay
Cells were seeded into 24-well plates and cultured to confluence.
Cell migration after scratch wounding was performed as described
previously (Xue et al., 2007). To prevent cell proliferation, cells
were pretreated with mitomycin C (10 mgml1), which was applied
to the cells 2 hours before wounding and removed with three washes
with phosphate buffered saline (PBS). The percentage of cell
migration was calculated as follows: (number of migrated MMP
siRNAs-treated cells/number of migrated scrambled siRNA-treated
cells) 100.
Western blotting
Keratinocytes were washed three times with PBS and lysis buffer
(0.15M NaCl, 0.01mM phenylmethlysulfonyl fluoride, 1% NP-40,
0.02M Tris, 6 M urea/H2O) was added. Cell lysates were centrifuged
at 10,000 g for 15minutes. Supernatants were assayed for total
protein concentrations using the BCA Protein Assay kit (Pierce
Biotechnology Inc., Rockford, IL). Equal amount of protein was
loaded and separated by 10% SDS-polyacrylamide gel electro-
phoresis and transferred to a polyvinylidene difluoride membrane.
The primary antibodies used were rabbit anti-phosphorylated forms
of p38, and ERK2, goat anti-human K14 (1:1,000 dilutions;
Santa Cruz Biotechnology Inc., Santa Cruz, CA), mouse anti-human
K10 (Sigma), and rabbit anti-phosphorylated EGFR (Y1173) (R&D
Systems, Minneapolis, MN). Membranes were stripped by low pH
and reprobed with different primary antibodies. Immunoreactivity
was detected with the ECL detection system (Amersham, Piscataway,
NJ). Anti-human b-actin antibody was included to normalize against
unequal loading.
BrdU incorporation
Keratinocytes were cultured on permanox slides. BrdU was added
into culture medium to a final concentration of 10 mgml1. After
2 hours, cells were washed with PBS and fixed with cold acetone.
Immunohistochemical and immunofluorescent staining
Foreskins were fixed in 10% formalin and tissues sections (4 mm)
were incubated with mouse anti-human MMP-2 and MMP-9
antibodies (R&D Systems) overnight. Mouse IgG was used as a
negative control. Tissue sections were stained with DAKO
LSABþ Systems stain kit (DAKO Corporation, Carpenteria, CA) and
counterstained with hematoxylin and Scotts Bluing Solution.
Cultured keratinocytes on permanox slides were fixed with cold
acetone and blocked by 5% horse serum in PBS, and incubated with
mouse/goat anti-human MMP-9 antibodies, rabbit anti-human
MMP-2 antibody, and rabbit anti-human active caspase-3 antibody
(R&D Systems); mouse anti-BrdU antibody (Sigma); mouse anti-
human K10 antibody; and goat anti-human K14 antibody overnight
at 4 1C. After washing with PBS, cells were incubated with
anti-rabbit IgG conjugated with Cy3 (red), anti-goat IgG conjugated
with FITC (green), and anti-mouse IgG conjugated with FITC or Cy3
(Invitrogen Corporation, Carlsbad, CA). Cells were washed with PBS,
mounted with ProLongGold anti-fade reagent with or without
DAPI (Invitrogen Corporation), and observed with a fluorescence
microscope (Nikon ECLIPSE 80i; Nikon Corporation, Sydney,
Australia). Images were acquired and processed using a Nikon
digital camera and software (Diagnostic Instruments, Sydney,
Australia) and ImageJ (http://rsb.info.nih.gov/ij).
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Apoptosis detection
Cell apoptosis was detected using modified ethidium bromide and
acridine orange staining assay as described previously (Ribble et al.,
2005). Briefly, 1.5 104 cells per well were seeded in a 96-well
plate. Forty-eight hours post transfection, the plate was centrifuged at
129 g for 5minutes using a Beckman Model TJ-6 centrifuge with
inserts for 96-well plates. An ethidium bromide and acridine orange
dye mix (8ml) was added to each well and cells were viewed with an
inverted fluorescence microscope. Tests were performed in tripli-
cate, counting a minimum of 100 cells for each treatment.
Gelatin zymography
MMP-2 and MMP-9 protein secretion and activation in the culture
supernatants was measured by gelatin zymography under non-
reducing conditions as described previously (Herron et al., 1986).
Equal loading was determined by total protein concentration.
Statistical analysis
Significance was determined by one-way analysis of variance
followed by post hoc tests. P values less than 0.05 were considered
statistically significant.
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